News Quantified

ANAB – anaptysbio, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Johnson Rice.

Anaptys Announces Stock Repurchase Plan

AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.

AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $42.00. They now have an "overweight" rating on the stock.

AnaptysBio, Inc. (NASDAQ: ANAB) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.

11.7%

BEAT

-0.9%

MISS

-12.9%

MISS

Form 4 ANAPTYSBIO, INC For: Mar 25 Filed by: Schmid John P.

Form 8-K ANAPTYSBIO, INC For: Mar 24

Form SCHEDULE 13G ANAPTYSBIO, INC Filed by: First Light Asset Management, LLC

Form 10-K ANAPTYSBIO, INC For: Dec 31

Form 8-K ANAPTYSBIO, INC For: Feb 27

Top News Gainers

3/2 Form 10-K ANAPTYSBIO, INC For: Dec 31 18.7%

6/21 AnaptysBio Inc (NASDAQ: ANAB) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. 11.8%

12/10 Form SC 13G/A ANAPTYSBIO, INC Filed by: FMR LLC 8.2%

10/1 Investors Yawn As Biotech Puts Up Positive Test Results — For 2 Patients [Investor's Business Daily] 8.1%

11/22 Form SC 13G ANAPTYSBIO, INC Filed by: TANG CAPITAL PARTNERS LP 7.8%

3/3 AnaptysBio Inc (NASDAQ: ANAB) had its price target lowered by analysts at SunTrust Banks, Inc. from $15.00 to $14.00. They now have a "hold" rating on the stock. 6.3%

5/1 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB 5.4%

4/17 Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of AnaptysBio, Inc. (ANAB) 5.2%

4/8 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTI Surgical, AnaptysBio, Hanmi Financial, and HF Foods Group and Encourages Investors to Contact the Firm 5.2%

4/13 CLASS ACTION UPDATE for ANAB, VMW and ZM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders 5.0%

Top News Decliners

8/19 Form 8-K ANAPTYSBIO, INC For: Aug 16 -13.6%

9/30 Form 8-K ANAPTYSBIO, INC For: Sep 30 -11.8%

6/24 AnaptysBio Inc (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at SunTrust Banks, Inc.. -11.4%

6/21 AnaptysBio Inc (NASDAQ: ANAB) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. -8.9%

8/10 AnaptysBio Prepares for a Potential Gear Shift [The Motley Fool] -7.8%

3/10 Form 4 ANAPTYSBIO, INC For: Mar 10 Filed by: Suria Hamza -7.2%

2/12 Form SC 13G/A ANAPTYSBIO, INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C. -7.0%

9/25 Form 8-K ANAPTYSBIO, INC For: Sep 24 -6.8%

3/31 ANAPTYSBIO SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB -5.9%

3/27 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm -5.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day